Anal cancer diagnosis and treatment statistics

Routes to diagnosis

'GP referral' is the most common route to diagnosing anal cancer

Around 4 in 10 (39%) of anal cancer cases in England are diagnosed following a routine or urgent GP referral (but not under the ‘two-week wait’ referral route). This proportion is high compared with the average across all cancer types.[1]

Almost a third (31%) of anal cancer cases in England are diagnosed via the ‘two-week wait’ referral route.[1]

Almost 3 in 20 (13%) of anal cancer cases in England are diagnosed after presenting as an emergency. The proportion of patients presenting as an emergency is slightly higher for males (14%) than females (12%), and rises with increasing age, reaching a peak in 85+ year-olds (24%). Emergency presentations for anal cancer also show an association with deprivation, with the proportion of patients presenting as an emergency being highest in people living in the most deprived areas in England.[1]

Anal Cancer (C21), Percentage of Cases by Route to Diagnosis, Adults Aged 15-99, England, 2006-2013

References

  1. National Cancer Intelligence Network. Routes to Diagnosis 2006-2013 workbook. London: NCIN; 2015.

About this data

Data is for UK, 2006-2013, ICD-10 C21

Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2006-2013 due to the small number of cases.

'14-day / Two-week wait'

England meets the standard for their country on the percentage of patients first seen by a specialist within two weeks of urgent GP referral for suspected cancer.[1]

'Two-week wait' supports early diagnosis as spotting cancer early is important for improving survival, so it is important that patients with potential cancer symptoms are referred promptly.

'31-day wait'

England, Scotland and Ireland all meet the standard for their country on the percentage of patients that receive their first cancer treatment within 31 days of a decision to treat, while Wales does not meet the standard for their country.[1-4]

The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.

'62-day wait'

None of the countries in the UK meet the standard for their country on the percentage of patients receiving their first definitive treatment for cancer within two months of a GP referral for suspected cancer.[1-4]

The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.

Cancer waiting times coding and standards are different in each country and so comparisons should not be made between countries, only each country against their own measures.

Lower Gastrointestinal Cancers, Waiting Times, UK countries, 2014-2015

    England Wales Scotland (bowel cancer only) Northern Ireland
'14-day wait': seen by specialist following referral Performance 93.5%      
Standard 93%      
Performance against standard Meets standard      
'31-day wait': receipt of first treatment following decision to treat Performance 98.1% 97.1% 98.1% 98.9%
Standard 96% 98% 95% 98%
Performance against standard Meets standard Does not meet standard Meets standard Meets standard
'62-day wait': receipt of first treatment following referral Performance 73.3% 75.3% 90.5% 66.1%
Standard 85% 95% 95% 95%
Performance against standard Does not meet standard Does not meet standard Does not meet standard Does not meet standard

Data not available for '14-day wait' in Wales, Scotland or NI.
Data not available for '31- or 62-day wait' in England.
Data for Scotland for bowel cancer only.

References

  1. NHS England. Cancer waiting times.  Accessed May 2015.
  2. StatsWales. Cancer waiting times. Accessed May 2015. 
  3. ISD Scotland. Cancer Waiting Times. Accessed June 2015. 
  4. Department of Health, Social Services and Public Safety. Cancer Waiting Times. Accessed June 2015.

About this data

Data is for UK, 2014-2015, ICD-10 C17-C21, C26

Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Bowel cancer is part of the group 'Lower Gastrointestinal cancer' for cancer waiting times data. Codes vary per country but broadly include: small intestine, colon, rectosigmoid junction, rectum, anus and anal canal, other and ill-defined digestive organs, secondary cancers of small intestine, large intestine, rectum, and unspecified digestive organs.

Last reviewed:

The National Cancer Patient Experience Survey monitors patients’ self-reported satisfaction with each step of the cancer pathway in England, providing information to drive improvements in cancer care.[1] The survey has been conducted annually since 2010.

Overall, most cancer patients in England report positive experiences of cancer care. However patient experience varies along the cancer pathway, and by gender, ethnicity, age, deprivation, and cancer type. Satisfaction scores tend to be higher for experiences with Clinical Nurse Specialists and other hospital staff, and lower for experiences with GPs and general practice staff. Patients who report more positive experiences of cancer diagnosis and treatment tend to be male, white, older, and less deprived.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 1.9 out of 5 based on 10 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page